Takeda Pharmaceutical Company Limited (FRA:TKDA)

FRA:TKDA Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	39,457	41,702	40,227	46,820	40,204	47,993
Market Cap Growth	-3.94%	3.67%	-14.08%	16.45%	-16.23%	10.12%
Enterprise Value	64,445	72,212	70,368	75,247	67,122	83,681
Last Close Price	12.30	13.70	12.40	13.72	11.67	14.13
PE Ratio	207.14	62.54	45.57	21.33	23.57	16.57
PS Ratio	1.55	1.47	1.54	1.68	1.52	1.95
PB Ratio	0.96	0.97	0.90	1.06	0.95	1.20
P/FCF Ratio	6.73	7.88	12.14	8.08	5.42	6.92
P/OCF Ratio	5.71	6.39	9.16	6.92	4.83	6.16
EV/Sales Ratio	2.63	2.55	2.69	2.70	2.54	3.40
EV/EBITDA Ratio	9.83	9.48	10.04	8.46	7.65	11.04
EV/EBIT Ratio	24.20	20.76	22.99	17.54	15.09	25.62
EV/FCF Ratio	11.00	13.65	21.23	12.99	9.06	12.07
Debt / Equity Ratio	0.73	0.73	0.75	0.77	0.85	0.98
Debt / EBITDA Ratio	4.37	3.96	4.57	3.79	4.07	5.16
Debt / FCF Ratio	5.10	5.94	10.10	5.81	4.81	5.64
Asset Turnover	0.30	0.31	0.29	0.30	0.27	0.25
Inventory Turnover	1.24	1.30	1.30	1.36	1.40	1.34
Quick Ratio	0.65	0.44	0.50	0.49	0.73	1.00
Current Ratio	1.37	1.01	1.11	0.97	1.21	1.53
Return on Equity (ROE)	0.47%	1.52%	2.12%	5.27%	4.24%	7.60%
Return on Assets (ROA)	2.09%	2.40%	2.15%	2.85%	2.88%	2.06%
Return on Capital (ROIC)	2.44%	2.84%	2.61%	3.57%	3.62%	2.59%
Return on Capital Employed (ROCE)	3.90%	4.80%	3.90%	5.40%	5.40%	3.80%
Earnings Yield	0.48%	1.60%	2.20%	4.69%	4.24%	6.04%
FCF Yield	14.85%	12.69%	8.24%	12.37%	18.44%	14.44%
Dividend Yield	2.16%	8.84%	9.29%	9.08%	11.43%	9.81%
Payout Ratio	935.06%	280.28%	199.34%	88.14%	123.30%	75.36%
Buyback Yield / Dilution	-0.65%	-1.58%	-0.67%	0.46%	-0.23%	-0.47%
Total Shareholder Return	1.51%	7.26%	8.62%	9.55%	11.20%	9.34%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.